bioRxivCancer BiologyPreprint
Intratumoral CXCL12 Gradients Contextualize Tumor Cell Invasion, Migration and Immune Suppression in Breast Cancer
Dimitra P. AnastasiadouiD, Nicole Couturier, Sakshi GoeliD, Dimitrios G ArgyrisiD, Stepan VodopyanoviD, Luis Rivera SancheziD, Edgar Gonzalez, Jesse KregeriD, Anthony J. GriffeniD, Abigail Kazakov, Joseph Burt, Natasha Recoder, Camille L. DuraniD, Allison S. HarneyiD, Agathe QuesneliD, Panagiota S. FilippouiD, Vasileios Panagiotis E. LenisiD, Suryansh Shukla, David R. EntenbergiD, Aliona ZintiridouiD, Xiaoming Chen, Robert J. EddyiD, Maja H. OktayiD, John S. CondeelisiD, Nikolaos S. Karagiannis, , George S. KaragiannisiD
Abstract
Although the CXCL12/CXCR4 pathway has been prior investigated for its prometastatic and immuno- suppressive roles in the tumor microenvironment, evidence on the spatiotemporal regulation of these hallmarks has been lacking. Here, we demonstrate that CXCL12 forms a gradient specifically around cancer cell intravasation doorways, also known as Tumor Microenvironment of Metastasis (TMEM) doorways, thus facilitating the chemotactic translocation of prometastatic tumor cells expressing CXCR4 toward the perivascular TMEM doorways for subsequent entry into peripheral circulation. Fur- thermore, we demonstrate that the CXCL12-rich micro-environment around TMEM doorways may cre- ate immunosuppressive niches, whereby CD8+ T cells, despite being attracted to these regions, often exhibit reduced effector functions, limiting their efficacy. While the CXCL12/CXCR4 pathway can mini- mally influence the overall composition of immune cell populations, it biases the distribution of CD8+ T cells away from TMEM doorways, justifying its prior-established role as immunosuppressive factor for CD8+ T cells. Our research suggests that the complex interactions between CXCL12 and the various tumor and immune cell types contributes not only to the completion of the initial steps of the metastatic cascade, but also offers an immunological "sanctuary" to prometastatic tumor cells homed around TMEM doorways. Overall, our study enhances our current understanding on the mechanisms, via which CXCL12 orchestrates tumor cell behavior and immune dynamics, potentially guiding future thera- peutic strategies to combat breast cancer metastasis and improve anti-tumor immunity.
- organism: human
- assay: bulk RNA-seq
- research focus: cancer & tumor microenvironment
- approach: experimental assay
- Citations
- 1
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Dying cell-released exosomal CXCL1 promotes breast cancer metastasis by activating TAM/PD-L1 signaling
- Signaling events at TMEM doorways provide potential targets for inhibiting breast cancer dissemination
C. R. Surve, C. L. Duran, … J. S. Condeelis·bioRxiv·Jan 8, 2024
- Activating the CXCR3/CXCL10 pathway overrides tumor immune suppression by enhancing immune trafficking and effector cell priming in head and neck squamous cell carcinoma
Cheyanne K. Shinn, Robert Saddawi‐Konefka, … Tracy M. Handel·bioRxiv·Apr 24, 2025
- The CXCL10/CXCR3 axis is essential for sustaining immunological dormancy in breast cancer
Alev Yilmaz, Lisa Haerri, … Curzio Rüegg·bioRxiv·Sep 26, 2025
- Cell-to-cell variability of dynamic CXCL12-CXCR4 signaling and morphological processes in chemotaxis
K. K. Y. Ho, S. Srivastava, … K. E. Luker·bioRxiv·May 19, 2022
- S100A9-Dependent CXCR2hi Neutrophils Mediate Systemic Immune Suppression and Checkpoint Resistance in Metastatic TNBC
Fulya Koksalar Alkan, Ahmet B. Çağlayan, … Hasan Körkaya·bioRxiv·Jul 8, 2026